Clinical Trial Update: Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase crossover feasibility trial evaluating a portable artificial pancreas device with Zone-MPC and HMS for adapting insulin regimens and bas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Sansum Diabetes Research Institute | Conditions: Type 1 Diabetes Mellitus | EARLY_Phase 1 | Status: COMPLETED